Rodent models of fatty liver diseases

Rodent models of fatty liver diseases

Fatty liver diseases including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide. ALD and NAFLD encompass a broad spectrum of liver disorders ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis and sup...

Full description

Bibliographic Details
Main Author:	Adeline Bertola
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2018-03-01
Series:	Liver Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S2542568418000156

Similar Items

The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models
by: Bayan Abdulhafid Aljahdali, et al.
Published: (2023-06-01)

How useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?
by: Jake Peter Mann, et al.
Published: (2016-11-01)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
by: Laura Valenzuela-Vallejo, et al.
Published: (2023-05-01)

Coffeeberry Activates the CaMKII/CREB/BDNF Pathway, Normalizes Autophagy and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model
by: Meng-Chun Lu, et al.
Published: (2021-10-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
by: Negar Aasadollahei, et al.
Published: (2023-03-01)

Cytokines and fatty liver diseases
by: Lukas Niederreiter, et al.
Published: (2018-03-01)

Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease
by: Jing Ren, et al.
Published: (2022-01-01)

Inactivity and fatty liver disease
by: Marek Rác, et al.
Published: (2016-12-01)

Inactivity and fatty liver disease
by: Marek Rác, et al.
Published: (2016-12-01)

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
by: Laure Monteillet, et al.
Published: (2018-10-01)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01)

Fatty liver in a child: Looking beyond nonalcoholic fatty liver disease
by: Jaya Agarwal, et al.
Published: (2021-01-01)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
by: Wang Xin, et al.
Published: (2011-12-01)

Rodent Models of Huntington’s Disease: An Overview
by: Giulio Nittari, et al.
Published: (2023-12-01)

Experimental Rodent Models of Cardiovascular Diseases
by: Tian Jia, et al.
Published: (2020-12-01)

Modeling Parkinson’s Disease: Not Only Rodents?
by: Maria Shadrina, et al.
Published: (2021-08-01)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
by: Seong Hee Kang, et al.
Published: (2021-04-01)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
by: Eun-Ju Cho, et al.
Published: (2021-11-01)

Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers
by: Sarit Anavi, et al.
Published: (2017-10-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Nonalcoholic fatty liver disease stratification by liver lipidomics
by: Olga Vvedenskaya, et al.
Published: (2021-01-01)

Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.
by: Andrea Cruz-Baquero, et al.
Published: (2017-01-01)

Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic Failure
by: Nasser Hashemi Goradel, et al.
Published: (2015-09-01)

Non-alcoholic fatty liver disease
by: Pavlides, M, et al.
Published: (2019)

Nonalcoholic Fatty Liver Disease and Ayurveda
by: Sanjeev Sharma, et al.
Published: (2023-01-01)

Postprandial dysfunction in fatty liver disease
by: Josephine Grandt, et al.
Published: (2023-04-01)

History of Nonalcoholic Fatty Liver Disease
by: Amedeo Lonardo, et al.
Published: (2020-08-01)

Glucocorticoid-Induced Fatty Liver Disease
by: Rahimi L, et al.
Published: (2020-04-01)

The AMPK pathway in fatty liver disease
by: Chunqiu Fang, et al.
Published: (2022-08-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01)

Non-Alcoholic Fatty Liver Disease
by: Hui-Hui Tan MRCP(UK), FAMS, et al.
Published: (2010-03-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease
by: Guglielmina Chimienti, et al.
Published: (2021-09-01)

Drug-Induced Fatty Liver Disease
by: A. P. Pereverzev, et al.
Published: (2020-06-01)

Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
by: Ching-Sheng Hsu, et al.
Published: (2012-10-01)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
by: Bilon Khambu, et al.
Published: (2018-09-01)